Table 2.
Model | HR | 95% CI | P |
---|---|---|---|
Outcome, PFS | |||
LDH alone | 1.59 | 1.17 to 2.17 | .003 |
Serum-β2 M alone | 1.70 | 1.27 to 2.28 | .0004 |
Serum-β2 M and LDH* | 2.24 | 1.51 to 3.31 | < .0001 |
FLIPI* | 2.41 | 1.63 to 3.56 | < .0001 |
Outcome, OS | |||
LDH alone | 2.46 | 1.49 to 4.07 | .0004 |
Serum-β2 M alone | 2.22 | 1.31 to 3.76 | .003 |
Serum-β2 M and LDH* | 3.95 | 2.01 to 7.78 | < .0001 |
FLIPI* | 3.81 | 1.92 to 7.54 | .0001 |
Abbreviations: FLIPI, Follicular Lymphoma International Prognostic Index; HR, hazard ratio; LDH, lactate dehydrogenase; PFS, progression-free survival; OS, overall survival.
HRs show comparisons between high- versus low-risk groups.